Stock-Based Compensation - 2022 Inducement Plan (Details) - shares |
1 Months Ended | |||||
|---|---|---|---|---|---|---|
Jan. 31, 2026 |
Nov. 30, 2025 |
Nov. 30, 2024 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Dec. 31, 2022 |
|
| Stock-Based Compensation | ||||||
| Common stock reserved for issuance (in shares) | 24,838,242 | 20,469,237 | ||||
| 2022 Inducement Plan | ||||||
| Stock-Based Compensation | ||||||
| Common stock reserved for issuance (in shares) | 19,642 | |||||
| Shares available for future issuance (in shares) | 52,812 | |||||
| Additional common stock reserved under the plan (in shares) | 32,485 | 35,714 | 35,714 | |||
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of additional shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|